Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis.
维索美汀通过 STAT3/LDHB 轴重编程破骨细胞代谢来减轻病理性骨丢失
期刊:Research (Wash D C)
影响因子:
doi:10.34133/research.0784
Yuan Putao, Feng Zhenhua, Yang Haotian, Xue Hong, Xie Hongwei, Dai Zihan, Wang Haoming, Liu Ying, Pan Bin, Song Hongpu, Ye Huali, Xie Ziang, Shi Peihua, Sun Xuewu
